Clinical manifestations are complex and often involve multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological evaluation.
Platforms can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the narrow integrated management of the airway associated with hyperglycemia. The platform serves a team of domestic and foreign experts in the field of genetic metabolism in the Chinese international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.